Related Experiment Videos
Renal involvement in Churg-Strauss syndrome
E J Clutterbuck1, D J Evans, C D Pusey
1Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London.
Summary
Churg-Strauss syndrome often involves severe kidney damage, contrary to previous beliefs. Early and aggressive treatment, including immunosuppressants, can significantly improve renal function in affected patients.
Area of Science:
- Nephrology
- Rheumatology
- Systemic Vasculitis
Background:
- Churg-Strauss syndrome (CSS), a form of systemic vasculitis, is typically characterized by asthma, eosinophilia, and necrotizing inflammation.
- Renal involvement in CSS is often considered uncommon and mild, with limited data on its severity and treatment outcomes.
Observation:
- This study reviewed 19 patients with CSS, revealing a high prevalence (84%) of renal involvement.
- A significant proportion of patients presented with severe kidney disease, including nephrotic syndrome, elevated creatinine levels, and the need for dialysis.
- Focal segmental glomerulonephritis with necrotizing features and crescent formation was the predominant renal biopsy finding.
Findings:
- High-dose prednisolone was effective for milder CSS cases.
- Combined immunosuppressive therapy (azathioprine, cyclophosphamide) or plasma exchange improved outcomes in severe cases.
- Renal function improved in 14 out of 16 patients, with ten maintaining normal function long-term.
Implications:
- CSS frequently causes severe renal disease, necessitating a reassessment of its clinical presentation.
- Aggressive immunosuppressive strategies are crucial for managing severe renal involvement in CSS.
- Prompt diagnosis and treatment can lead to favorable long-term renal outcomes in CSS patients.